EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein-Barr virus-associated gastric cancer.

Soldan SS, Anderson EM, Frase DM, Zhang Y, Caruso LB, Wang Y, Deakyne JS, Gewurz BE, Tempera I, Lieberman PM, Messick TE.

Open source

DOI: 10.1007/s10120-021-01193-6
Published: 2021-04-30
Container: Gastric Cancer
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s10120-021-01193-6,
  title = {EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein-Barr virus-associated gastric cancer.},
  author = {Soldan SS and  Anderson EM and  Frase DM and  Zhang Y and  Caruso LB and  Wang Y and  Deakyne JS and  Gewurz BE and  Tempera I and  Lieberman PM and  Messick TE.},
  year = {2021},
  journal = {Gastric Cancer},
  doi = {10.1007/s10120-021-01193-6},
  url = {https://doi.org/10.1007/s10120-021-01193-6}
}

RIS

TY  - JOUR
TI  - EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein-Barr virus-associated gastric cancer.
AU  - Soldan SS
AU  -  Anderson EM
AU  -  Frase DM
AU  -  Zhang Y
AU  -  Caruso LB
AU  -  Wang Y
AU  -  Deakyne JS
AU  -  Gewurz BE
AU  -  Tempera I
AU  -  Lieberman PM
AU  -  Messick TE.
PY  - 2021
JO  - Gastric Cancer
DO  - 10.1007/s10120-021-01193-6
UR  - https://doi.org/10.1007/s10120-021-01193-6
ER  -

APA

SS, S., EM, A., DM, F., Y, Z., LB, C., Y, W., JS, D., BE, G., I, T., PM, L., & TE., M. (2021). EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein-Barr virus-associated gastric cancer.. Gastric Cancer. https://doi.org/10.1007/s10120-021-01193-6

Source records

europe-pmc · retrieved 2026-09-27T03:16:25.315Z